Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana, Billings
Bozeman Health Deaconess Hospital - Bozeman Health Cancer Center, Bozeman
Bozeman Health Deaconess Hospital - Bozeman Health Clinical Research, Bozeman
他1件

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/28更新 · NCT07144280

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

SCL Health - Montana, Billings
SCL Health - Montana, Billings

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/25更新 · NCT06758401

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

Community Hospital of Anaconda, Anaconda
Billings Clinic Cancer Center, Billings
Bozeman Health Deaconess Hospital, Bozeman
他6件

被験者募集中第2相

18歳以上 · 全性別 · 2026/09/24更新 · NCT03191149

Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

Logan Health Research, Kalispell

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/15更新 · NCT06899126

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

St. Vincent Frontier Cancer Center-Research ( Site 0105), Billings

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/08更新 · NCT06345729

Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

St. Vincent Frontier Cancer Center, Billings

被験者募集中第2相

18歳以上 · 全性別 · 2026/08/26更新 · NCT07288177

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

Intermountain Health - St. Vincent Frontier Cancer Center, Billings

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/06/30更新 · NCT06162221

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Community Hospital of Anaconda, Anaconda
Billings Clinic Cancer Center, Billings
Bozeman Health Deaconess Hospital, Bozeman
他3件

被験者募集中第2相

18歳以上 · 全性別 · 2026/06/03更新 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Community Hospital of Anaconda, Anaconda
Billings Clinic Cancer Center, Billings
Bozeman Health Deaconess Hospital, Bozeman
他3件

被験者募集中第2相

18歳以上 · 全性別 · 2026/05/06更新 · NCT06116682

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Community Hospital of Anaconda, Anaconda
Billings Clinic Cancer Center, Billings
Bozeman Health Deaconess Hospital, Bozeman
他3件

被験者募集中第2相

18 Minutes · 全性別 · 2026/05/05更新 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Community Hospital of Anaconda, Anaconda
Billings Clinic Cancer Center, Billings
Bozeman Health Deaconess Hospital, Bozeman
他3件

被験者募集中第2/3相

18歳以上 · 全性別 · 2026/05/05更新 · NCT06616584

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Community Hospital of Anaconda, Anaconda
Billings Clinic Cancer Center, Billings
Montana Cancer Consortium NCORP, Billings
他5件

被験者募集中観察研究

18歳以上 · 全性別 · 2026/03/17更新 · NCT06418204

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Billings

被験者募集中観察研究

全年齢 · 全性別 · 2025/10/28更新 · NCT03452774

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。